Skip to content

Optical Diagnosis With vs. Without Three-Dimensional Imaging for Small and Diminutive Colorectal Polyps

Optical Diagnosis With vs. Without Three-Dimensional Imaging for Small and Diminutive Colorectal Polyps: A Prospective Randomized Controlled Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06922877
Enrollment
458
Registered
2025-04-11
Start date
2025-05-01
Completion date
2026-04-30
Last updated
2026-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Adenomas, Colorectal Polyps

Keywords

three dimension imaging device, colorectal polyps, colorectal adenomas

Brief summary

This study investigated whether adding a three-dimensional (3D) imaging view during colonoscopy helps doctors classify small colon polyps more accurately than standard colonoscopy without 3D. Polyps are small growths in the colon that may develop into cancer over time. When doctors remove polyps, they often examine them closely during the procedure to judge how likely they are to be precancerous-a process called optical diagnosis. In this study, two approaches to optical diagnosis were compared: diagnosis using standard colonoscopy without 3D, and diagnosis using the same colonoscopy with additional 3D imaging. Both groups used the same classification systems (JNET and WASP) to identify polyp type; the only difference was whether 3D imaging was used. The main question was whether adding 3D improves the agreement between the doctor's diagnosis during colonoscopy and the final laboratory diagnosis of the removed polyp. The study also collected safety information. Participants were randomly assigned to one of the two groups, like flipping a coin. Regardless of group, all participants underwent an initial colonoscopy to detect polyps, a second colonoscopy to remove polyps and perform optical diagnosis, and a follow-up period of up to 30 days to monitor for side effects. The study included adults with at least one colon polyp smaller than 10 mm that did not require a more advanced type of removal called ESD.

Interventions

DIAGNOSTIC_TESTOptical diagnosis based on JNET classification with WASP features (no 3D assistance)

Real-time optical diagnosis of colorectal polyps \<10 mm before polypectomy, based on the JNET classification with additional WASP features for JNET Type 1 lesions, using standard high-definition colonoscopy without 3D assistance.

DIAGNOSTIC_TESTOptical diagnosis based on JNET classification with WASP features plus 3D imaging assistance

Real-time optical diagnosis of colorectal polyps \<10 mm before polypectomy, based on the JNET classification with additional WASP features for JNET Type 1 lesions, using standard high-definition colonoscopy with 3D imaging assistance.

Sponsors

Xijing Hospital of Digestive Diseases
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults aged ≥18 years; * Underwent non-3D white-light colonoscopy with at least one colorectal polyp identified; * Endoscopically estimated polyp size \<10 mm; * No indication for endoscopic submucosal dissection (ESD); * Scheduled for inpatient polypectomy; * Provided written informed consent.

Exclusion criteria

* History of any polypectomy; * History of colorectal surgery; * Inflammatory bowel disease (Crohn's disease or ulcerative colitis); * Hereditary polyposis syndromes; * Concurrent colorectal cancer; * Contraindications to colonoscopy (e.g., severe cardiopulmonary insufficiency); * Coagulopathy or failure to discontinue antithrombotic agents; * Inability to cooperate with procedures; * Pregnancy or lactation; * Refusal to participate or inability to give informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Overall diagnostic concordance of endoscopic polyp classification1-7 days after polypectomyThe overall proportion of correct classifications by endoscopy (3D vs. non-3D) compared to the gold standard (pathology) at the lesion level, across all polyp types.

Secondary

MeasureTime frameDescription
Diagnostic confidenceDuring the endoscopic procedure, immediately after optical diagnosisThe proportion of lesions classified with high versus low diagnostic confidence by the endoscopist during real-time optical diagnosis. High confidence was defined as clear visualization of both vascular and surface patterns permitting a definitive JNET classification; low confidence was defined as suboptimal visualization or ambiguous features precluding a definitive classification.
Diagnostic concordance for adenomas and sessile serrated lesions (SSLs)1-7 days after polypectomyThe overall proportion of correct classifications by endoscopy compared with the gold standard (pathology) at the lesion level for adenomas and for sessile serrated lesions, respectively.
Diagnostic concordance for identifying patients requiring surveillance1-7 days after polypectomyThe proportion of patients for whom the surveillance interval assigned by optical diagnosis matches the interval assigned by pathology, according to the 2020 ESGE guideline. Surveillance intervals were determined based on all resected polyps, including those \>10 mm, reflecting real-world clinical practice.
Diagnostic characteristics (sensitivity, specificity, PPV, NPV) for adenomas and SSLs1-7 days after polypectomyDiagnostic performance measures for endoscopic classification (3D vs. non-3D) in detecting adenomas and sessile serrated lesions at the lesion level, using final pathology as the gold standard. Measures include sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV).
The colonoscopy-relevant adverse events1-30 days after polypectomyaspiration pneumonia, perforation, bleeding, splenic injury/rupture, death, or others requiring hospitalization within 30 days after the colonoscopy

Countries

China

Contacts

PRINCIPAL_INVESTIGATORZhiguo Liu, M.D

Xijing Hospital of Digestive DIsease

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 11, 2026